实用肝脏病杂志 ›› 2025, Vol. 28 ›› Issue (2): 286-289.doi: 10.3969/j.issn.1672-5069.2025.02.032

• 肝脓肿 • 上一篇    下一篇

细菌性肝脓肿患者临床特征与病原菌分析*

钟新梅, 闫莉莉, 张冬梅   

  1. 236000 安徽省阜阳市 安徽医科大学附属阜阳人民医院感染病科(钟新梅,闫莉莉);消化科(张冬梅)
  • 收稿日期:2023-10-16 出版日期:2025-03-10 发布日期:2025-03-11
  • 作者简介:钟新梅,女,35岁,大学本科,主治医师。E-mail:1073415310@qq.com
  • 基金资助:
    *安徽省自然科学基金青年基金资助项目(编号:2008085QH381)

Clinical feature and pathogen distribution in patients with bacterial liver abscess

Zhong Xinmei, Yan Lili, Zhang Dongmei   

  1. Department of Infectious Diseases, Fuyang People's Hospital Affiliated to Anhui Medical University, Fuyang 236000, Anhui Province, China
  • Received:2023-10-16 Online:2025-03-10 Published:2025-03-11

摘要: 目的 分析总结一组细菌性肝脓肿(BLA)患者的临床特征及病原菌分布情况。方法 2020年1月~2023年4月我院诊治的BLA患者60例,给予抗生素抗感染和脓腔穿刺抽脓或置管引流治疗。常规进行脓液培养和细菌分离鉴定。 结果 60例BLA患者基础疾病包括糖尿病和高血压,常见表现包括食欲下降、黄疸、腹膜炎、高热、寒战、腹痛、恶心呕吐及肝区叩痛;白细胞计数和中性粒细胞计数升高,血清丙氨酸氨基转移酶和天冬氨酸氨基转移酶升高,而血红蛋白和白蛋白水平降低;脓肿位于肝左叶、右叶、左右叶和左右叶交界处分别占26.7%、58.3%、8.3%和6.7%,脓肿直径为(3.6±0.9)cm;共分离出致病菌89株,其中肺炎克雷伯菌、大肠埃希菌和金黄色葡萄球菌分别为41株(46.1%)、18株(20.2%)和13株(14.6%);肺炎克雷伯菌对氨苄西林耐药率为100.0%,对7种抗生素耐药率为30.0%以上,而对另外9种抗生素耐药率在30%以下,18株大肠埃希菌对氨苄西林耐药率最高,对13种抗生素耐药率在30.0%以上,对另外3种抗生素耐药率在30.0%以下;经治疗13~28(15.2±3.6)d,本组60例BLA患者痊愈53例(88.3%),另有7例(11.7%)患者脓肿迁延,经多次治疗愈。结论 本组BLA患者存在糖尿病和高血压等基础疾病较多,好发于肝右叶,主要致病菌为肺炎克雷伯菌和大肠埃希菌,经抗感染联合经皮肝穿刺引流治疗可取得较理想的效果。

关键词: 细菌性肝脓肿, 临床特征, 病原菌, 脓肿穿刺抽脓, 治疗, 预后

Abstract: Objective This study was conducted to summarize the clinical feature and pathogen distribution in patients with bacterial liver abscess (BLA). Methods 60 consecutive patients with BLA were encountered in our hospital between January 2020 and April 2023, and all were treated with abscess puncture and aspiration or catheterization under ultrasound guidance at base of antibacterial therapy. Bacterial culture, separation and characterization was routinely carried out. Results The underlying diseases in our 60 patients with BLA were diabetes and hypertension, and the common symptoms and sign included anorexia, jaundice, peritonitis, high fever, chills, abdominal pain, nausea and vomiting and tapping pain in the liver area; the white blood cell counts, neutrophil cell counts, serum ALT and AST levels increased, while hemoglobin and albumin levels decreased; the abscess localized at left lobe, right lobe, double lobes and at junction of left and right lobes accounted for 26.7%, 58.3%, 8.3% and 6.7%, with the mean diameter of abscess of (3.6±0.9)cm; out of 89 strains of pathogens separated, the Lebsiella pneumonia, Escherichia coli and Staphylococcus aureus accounted for 46.1% (n=41), 20.2% (n=18) and 14.6% (n=13); the resistance of Lebsiella pneumonia to ampicillin was 100.0%, to seven antibiotics was greater than 30.0%, while to other nine antibiotics was less than 30%; the most Escherichia coliwas resistant to ampicillin, and the resistance to 13 antibiotics was over 30.0%, while to other three antibiotics was less 30%; at the end of 13-28 (15.2±3.6)day treatment, the recovery rate as showed by total disappearance of the abscess in our series was 88.3%, left 7 patients (11.7%)had their intrahepatic abscess uncurable, which disappeared after a little longer observation and management. Conclusion The BLA mostly often occurs in persons with diabetes and hypertension, and the common pathogens are Klebsiella pneumoniae and Escherichia coli. The percutaneous transhepatic drainage at base of antimicrobial treatment might obtain a promising outcomes.

Key words: Bacterial liver abscess, Clinical feature, Pathogen, Percutaneous transhepatic drainage, Therapy, Prognosis